📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Leukoreduced blood transfusion does not increase circulating soluble markers of inflammation: a randomized controlled trial. (2014)

First Author: Jiwaji Z

Attributed to: The Role of Cyclin-Dependent Kinase-9 Inhibition in Promoting the Resolution of Chronic Inflammation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/trf.12669

PubMed Identifier: 24796937

Publication URI: http://europepmc.org/abstract/MED/24796937

Type: Journal Article/Review

Volume: 54

Parent Publication: Transfusion

Issue: 10

ISSN: 0041-1132